Therapeutic Areas: NeuroModulation

Pioneering brain-changing breakthroughs

The field of neuromodulation is growing rapidly, with emerging applications incorporating a range of electromagnetic stimuli,
from magnetic fields to electric currents.

We know that working in an ever-evolving arena can be nerve-wracking.

Relax. We’ve got you and your neuromodulation device covered.

Proxima’s agile management approach allows our therapeutically-aligned team to adapt to your needs, while maintaining tight timelines and strategically managing the success of your device.

Our industry experts Our product Experience

INDUSTRY VETERANS IN MEDTECH

Our team has extensive global experience in the MedTech industry, including specific expertise in neuromodulation clinical trial research and management.

Our MedTech industry veterans have worked clinical studies for a wide range of neuro devices, including those that supported the PMA approval for the first neuromodulation device marketed in the US.

Our success in neuromodulation is rooted in providing you with what you need most—experience, transparency and reliability.

Deep Brain & NEuromodulation Experience

We use proven, effective solutions to manage your trial from start to finish.

At Proxima Clinical, we understand the complexities that come with conducting successful clinical trials. Our clinical and regulatory management strategy focuses on agility, efficiency, speed and a deep understanding of neuromodulation.

We work with class II and class III devices, whether they support a 510(k), PMA, post approval, or observational assessment.

Therapeutic indications:

Epilepsy and Lennox-Gastaut Syndrome (LGS)

Stroke Rehabilitation

Depression, Anxiety, and PTSD

Tinnitus

Weight Loss

Snoring, Sleep Apnea

Parkinson’s Disease

Neurostimulation and Electrophysiology

Essential Tremor

Migraine

Attention Deficit Disorder

Spinal Cord Injuries

Post-traumatic Stress Disorder

Urinary Incontinence

OAB

Team experience:

Vagus Nerve Stimulation (VNS)

Transcutaneous Stimulation

Deep Brain Stimulation (DBS)

Transcranial Magnetic Stimulation (TMS)

"The projects are very interesting as they deal a lot with niche products, and products that are seeking for a market. The people are fantastic, funny, open minded, tolerant, adorable, intelligent, competent, but above all they are motivated."

Position

First & Last Name

Position

First & Last Name

Developing medical technology for children has unique challenges. The Southwest National Pediatric Device Innovation Consortium (SWPDC) is a consortium that includes Baylor College of Medicine, Texas Children's Hospital, Texas A&M University, Rice University, University of Houston, and Fannin Innovation Studio. SWPDC is supported by an FDA grant to assist innovators with their pediatric device development as well as address their regulatory challenges. Proxima has been a strong partner for us in helping guide innovators quickly through their regulatory and clinical journey.